Skip to Main Content

Paper Details

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Leukemia
14
2022
Author NameAffiliation
Bruno C MedeirosStanford Comprehensive Cancer Center, Stanford University
Martin S TallmanMemorial Sloan Kettering Cancer Center
Michael HeuserHannover Medical School
Richard M Stone
  • 1 - 4

Datasets